The Role of Imaging in Soft Tissue Sarcoma Diagnosis and Management

Cimarron E Sharon; Richard J Straker 3rd; Giorgos C Karakousis

doi:10.1016/j.suc.2022.04.003

The Role of Imaging in Soft Tissue Sarcoma Diagnosis and Management

Surg Clin North Am. 2022 Aug;102(4):539-550. doi: 10.1016/j.suc.2022.04.003. Epub 2022 Jun 24.

Authors

Cimarron E Sharon¹, Richard J Straker 3rd¹, Giorgos C Karakousis²

Affiliations

¹ Department of Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
² Department of Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. Electronic address: giorgos.karakousis@uphs.upenn.edu.

PMID: 35952686
DOI: 10.1016/j.suc.2022.04.003

Abstract

The differential diagnosis of a soft tissue mass is broad, and an appropriate imaging workup is crucial to accurate identification. Additionally, imaging plays a critical role in soft tissue sarcoma (STS) staging and monitoring for disease progression. In this article, we discuss the different imaging modalities and their utility in the workup and surveillance of STS.

Keywords: (18)F-FDG PET-CT; Computed tomography; Magnetic resonance imaging; Soft tissue sarcomas; Ultrasound.

Publication types

Review

MeSH terms

Diagnostic Imaging
Fluorodeoxyglucose F18
Humans
Neoplasm Staging
Positron-Emission Tomography
Sarcoma* / diagnostic imaging
Sarcoma* / therapy
Soft Tissue Neoplasms* / diagnostic imaging
Soft Tissue Neoplasms* / therapy

Substances

Fluorodeoxyglucose F18